From November 1, 2023 to January 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 120,300 shares, representing 0.89% for $0.71 million under the buyback announced on April 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.86 USD | +2.53% | +0.21% | -13.52% |
15/03 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
13/03 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-13.52% | 64.43M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.